Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer

<div>Higher expression level of MRPL13 was correlated to shorter OS in BRCA. (a) From top to bottom are the expression values of MRPL13, patients’ survival status distribution, and the heatmap of MRPL13 expression in the low and high groups. (b) Higher expression level of MRPL13 was correlated to shorter OS in BRCA. (c) AUC analysis of MRPL13 in BRCA.</div>

Computational and Mathematical Methods in Medicine

fig4

Figure 4

Figure 4: Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer 

Figure 4 | Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer 